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Abstract	  
The	  dynamic	  process	  by	  which	  self-­‐renewing	  stem	  cells	  and	  their	  offspring	  proliferate	  and	  
differentiate	  to	  create	  the	  erythroid,	  myeloid	  and	  lymphoid	  lineages	  of	  the	  blood	  system	  has	  
long	  since	  been	  an	  important	  topic	  of	  study.	  A	  range	  of	  recent	  single	  cell	  and	  family-­‐tracing	  
methodologies	   such	   as	   massively	   parallel	   single-­‐cell	   RNA-­‐sequencing,	   mass	   cytometry,	  
integration	   site	   barcoding,	   cellular	   barcoding	   and	   transposon	   barcoding	   are	   enabling	  
unprecedented	  analysis,	  dissection	  and	  re-­‐evaluation	  of	  the	  hematopoietic	  tree.	  In	  addition	  
to	   the	   substantial	   experimental	   advances,	   these	  new	   techniques	  have	   required	   significant	  
theoretical	  development	   in	  order	   to	  make	  biological	  deductions	   from	   their	  data.	  Here	  we	  
review	   these	   approaches	   from	   both	   an	   experimental	   and	   inferential	   point	   of	   view,	  
considering	   their	   discoveries	   to	   date,	   their	   capabilities,	   limitations	   and	   opportunities	   for	  
further	  development.	  
Key	   words:	   hematopoietic	   tree,	   lineage	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   single	   cells,	   RNA	   sequencing,	   mass	  
cytometry,	  barcoding.	  	  
Introduction	  	  
	  
For	  decades,	  a	  central	  question	  in	  the	  study	  of	  hematopoiesis	  has	  been	  the	  identification	  of	  
lineage	   restricted	   cellular	   intermediates	   downstream	   of	   Hematopoietic	   Stem	   Cells	   (HSCs)	  
and	   the	   determination	   of	   the	   differentiation	   pathways	   that	   lead	   through	   them	   to	   the	  
production	  of	  mature	  blood	  and	  immune	  cells.	  This	   line	  of	  questioning	  has	  been	  driven	  by	  
the	  desire	  to	  better	  select	  and	  manipulate	  the	  cells	  that	  are	  transplanted	  into	  patients	  as	  a	  
consequence	   of	   blood	   related	   cancers	   and	   immune	   deficiency	   disorders.	   Increasing	   the	  
understanding	  of	  the	  mechanisms	  that	  drive	  one	  of	  the	  most	  studied	  stem	  cell	  models	  has	  
also	  stimulated	  the	  field.	  Hematopoietic	  development	  is	  a	  complex	  process	  with	  fascinating	  
properties	   as	   HSCs	   produce	   a	   highly	   diverse	   diffuse	   tissue	   that	   responds	   dynamically	   to	  
inducible	   perturbations	   such	   as	   infection	   and	   inflammation.	   The	   comparative	   ease	   with	  
respect	   to	   other	   tissues	  with	  which	   such	   a	   complex	   system	  of	   differentiating	   cells	   can	  be	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studied	   using	   in	   vitro	   cultures	   and	   transplantation	   systems	   might	   explain	   its	   popularity	  
among	  both	  experimental	  and	  theoretical	  researchers	  as	  a	  stem	  cell	  exemplar.	  
	  
The	   field	   of	   hematology	   has	   often	   progressed	   in	   parallel	   with	   newly	   developed	   technical	  
possibilities	   and	   single	   cell	   methods	   have	   long	   since	   been	   essential	   tools	   in	   this	  
investigation;	  the	  quintessential	  example	  being	  the	  discovery	  and	  characterisation	  of	  HSCs	  
[1–3]	  through	  the	  occurrence	  of	  Fluorescence-­‐Activated	  Cell	  Sorting	  (FACS),	  which	  enables	  
non-­‐destructive	   cellular	   phenotyping.	   The	   transplantation	   of	   single	   cells	   into	   irradiated	  
recipients	   to	   assess	   in	   vivo	   reconstitution	   capability	   is	   another	   example	  of	   a	   fundamental	  
single	  cell	  technique	  that	  was	  instrumental	  in	  revealing	  the	  diverse	  output	  of	  individual	  HSCs	  
(reviewed	   in	   [4]).	   Over	   sixty	   years’	   worth	   of	   detailed	   work	   has	   led	   to	   the	   canonical	  
hematopoietic	   tree,	  Fig	  1A,	  which	  has	  HSCs	  at	   its	   root	  and	  a	  branching	  collection	  of	  FACS	  
defined	  cell	  types,	  each	  believed	  to	  have	  a	  more	  restricted	  lineage	  potential	  than	  its	  parents	  
(Box	   1).	   In	   this	   tree,	   HSCs	   self-­‐renew	   and	   generate	   multi-­‐potent	   progenitors	   (MPP)	   that	  
differentiate	   and	   produce	   all	   blood	   cells.	   These	  MPPs	   commit	   to	   two	   separate	   branches,	  
becoming	   either	   Common	   Lymphoid	   or	   Common	   Myeloid	   Progenitors	   (CLPs	   and	   CMPs)	  
[5,6].	  CLPs	  give	  rise	  to	  further	  committed	  progenitors	  that	  produce	  lymphoid	  cells,	  such	  as	  T	  
and	  B	  lymphocytes,	  as	  well	  as	  innate	  lymphoid	  cells,	  while	  CMPs	  give	  rise	  to	  progenitors	  that	  
produce	   Granulocytes	   and	   Monocytes	   (GMP)	   amongst	   others,	   and	   progenitors	   that	   only	  
produce	  Megakaryocytes	  and	  Erythrocytes	  (MEP).	  Dendritic	  cells,	  another	  type	  of	   immune	  
cell,	  derive	  from	  both	  CLPs	  and	  GMPs	  [7,8]. 	  
 
Biological	   assumptions	   of	   the	   hematopoietic	   tree	   include:	   there	   are	   a	   finite	   number	   of	  
phenotypically	  definable	  categories	  of	  cell	   type,	  with	  definitive	  delineation	   in	  potential;	  all	  
cells	  within	  each	  category	  retain	  all	  potentials	  defined	  by	  that	  category;	  and	  once	  a	  cell	  loses	  
a	  potential,	  its	  offspring	  cannot	  regain	  it,	  leading	  to	  a	  hierarchical	  structure	  with	  no	  trans-­‐	  or	  
de-­‐differentiation.	   These	   assumptions	   map	   to	   a	   standard	   mathematical	   description:	  
hematopoietic	   development	   is	   identified	   with	   a	   graph,	   which	   is	   directed	   to	   indicate	  
sequential	   loss	   in	   potential,	   with	   vertices	   identified	   as	   cell	   types;	   edges	   in	   the	   graph	  
correspond	   to	   loss	   of	   potential	   through	   differentiation;	   and	   the	   directed	   graph	   is	   often	  
assumed	  to	  be	  a	  tree,	  where	  each	  cell	  has	  a	  only	  a	  single	  path	  of	  ancestral	  cell	  types	  leading	  
to	  hematopoietic	  stem	  cells.	  
	  
The	  precise	  meaning	  of	  the	  canonical	   tree	   in	  Fig	  1A	   is,	  however,	  subject	  to	   interpretation.	  
Arrows	   connecting	   cell	   types	   indicate	   progressive	   differentiation	   paths	   to	   terminally	  
differentiated	  cells,	  but	  whether	  they	  imply	  that	  every	  cell	  gives	  rise	  to	  all	  cell	  types	  beneath	  
it	  in	  the	  tree,	  or	  merely	  could	  do	  so	  with	  the	  right	  stimuli,	  or	  summarize	  at	  the	  population	  
level	   individual	   cell	   trajectories,	   is	   unclear.	   In	   other	  words,	   is	   the	   tree	   describing	  what	   is	  
possible	  or	  what	  actually	  occurs?	  Recent	  developments	  in	  single	  cell	  sequencing	  and	  single	  
cell	  lineage	  tracing	  demonstrate	  that	  it	  is,	  at	  best,	  a	  description	  of	  what	  is	  possible	  and	  are,	  
once	  again,	  challenging	  the	  paradigm	  of	  the	  hematopoietic	  tree	  thanks	  to	  higher	  resolution,	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high	   throughput	   in	   vivo	   measurements.	   The	   biological	   deductions	   from	   these	   data	   are	  
contingent	   on	   the	   complex	   statistical	   and	   mathematical	   methods	   necessary	   for	   their	  
analysis,	   which	   calls	   for	   an	   interdisciplinary	   effort	   to	   truly	   understand	   the	   abilities	   and	  
limitations	  that	  arise	  from	  both	  the	  experimental	  and	  data-­‐interrogation	  techniques.	  	  
	  
While	  the	  canonical	  tree	  provides	  a	  good	  description	  at	  the	  population	  level,	  new	  single	  cell	  
methodologies	   are	   enabling	   unprecedented	   analysis,	   dissection	   and	   re-­‐evaluation	   of	   the	  
hematopoietic	  tree.	  As	  other	  aspects	  of	  single	  cells	  studies	  have	  been	  reviewed	  elsewhere	  
[9],	  here	  we	  focus	  on	  recent	  results	  from	  ex	  vivo	  or	  in	  vivo	  single	  cell	  technologies	  assessing	  
their	   contribution	   in	   modifying	   our	   scheme	   of	   the	   hematopoietic	   tree,	   presenting	   the	  
abilities,	  limitations	  and	  promise	  of	  both	  the	  experimental	  and	  the	  data	  analytic	  aspects	  of	  
these	   technologies,	   and,	   in	   the	   end,	   questioning	   if	   a	   discrete	   directed	   decision	   tree	   will	  
ultimately	   prove	   to	   be	   the	   lasting	   quantitative	   descriptor	   of	   the	   process	   of	   blood	   system	  
development.	  	  
	  
Brief	  description	  of	  recent	  single	  cell	  methods	  used	  for	  hematopoiesis	  
	  
Recent	   technological	  advances	  of	   single	   cell	   study	  have	  proceeded	   in	   two	  complementary	  
directions:	   1)	   by	   enabling	   the	   interrogation	   of	   single	   cell	   state	   in	   a	   high	   dimensional	  way	  
(massively	  parallel	  single	  cell	  RNA	  sequencing	  (scRNA-­‐seq),	  mass	  cytometry);	  2)	  by	  allowing	  
long	   timescale	   in	   vivo	   lineage	   tracing	   of	   multiple	   initial	   single	   cells,	   referred	   to	   here	   as	  
barcoding	   (integration	   site	   barcoding,	   cellular	   barcoding,	   transposon	   barcoding).	   This	  
classification	  will	  be	  used	  throughout	  the	  review.	  	  
	  
Massively	   parallel	   scRNA-­‐seq	   uses	   next	   generation	   sequencing	   to	   determine	   the	  
transcriptome,	   the	   presence	   and	   quantity	   of	   mRNA,	   of	   thousands	   of	   individual	   cells	   in	   a	  
sample	  [10].	  Mass	  cytometry	  is	  a	  variant	  of	  flow	  cytometry	  in	  which	  antibodies	  are	  labelled	  
with	   heavy	   metal	   ion	   tags	   rather	   than	   fluorochromes	   [11].	   Mass	   cytometry	   circumvents	  
spectral	   overlap	   issues	   that	   come	   with	   traditional	   FACS	   enabling	   a	   greater	   number	   of	  
simultaneous	  measurements,	  but	  at	  the	  cost	  of	  destroying	  the	  cell.	  	  
	  
All	   forms	   of	   barcoding	   (integration	   site	   barcoding,	   cellular	   barcoding	   and	   transposon	  
barcoding),	  enable	  the	  familial	  identification	  of	  progeny	  of	  individual	  cells	  in	  vivo	  by	  marking	  
them	  with	  unique	  heritable	  genetic	  tags.	  Integration	  Site	  (IS)	  Barcoding	  uses	  the	  location	  of	  
the	  integration	  of	  a	  retrovirus	  or	  lentivirus	  as	  the	  heritable	  tag	  [12].	  Cellular	  Barcoding	  tags	  
each	   cell	  with	   an	   artificial	   sequence	   that	   is	   integrated	   into	   the	   genome	   via	   a	   retoviral	   or	  
lentiviral	   vector	   [13].	   Both	   IS	   and	   cellular	   barcoding	   require	   ex	   vivo	  manipulation	   of	   cells	  
followed	   by	   adoptive	   transfer	   to	   new	   hosts.	   In	   contrast,	   Transposon	   Barcoding	   uses	   an	  
inducible	  sleeping	  beauty	  transposon	  system	  to	  generate	  tags	  in	  situ	  [14].	  Inserted	  into	  the	  
embryonic	   stem	   cell	   of	   a	   mouse,	   a	   doxycycline	   trigger	   induces	   the	   transposon	   to	   jump	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elsewhere	  in	  the	  genome.	  The	  integration	  site	  of	  the	  transposon	  post-­‐trigger	  serves	  as	  the	  
cell’s	  tag,	  as	  with	  IS	  barcoding.	  	  
	  
High	  throughput	  scRNA-­‐seq	  and	  mass	  cytometry	  have	  been	  used	  to	  question	  whether	  cells	  
of	  the	  same	  phenotypic	  type	  would	  be	  identified	  as	  being	  of	  a	  common	  category	  based	  on	  
their	  cell-­‐internal	  state.	  Barcoding	  techniques	  question	   if	  each	  cell	  of	  a	  given	  category	  can	  
be	  treated	  interchangeably	  regardless	  of	  its	  antecedence.	  	  
	  
What	  has	  been	  questioned,	  and	  what	  we	  have	  learned	  so	  far	  using	  single	  cell	  methods	  
	  
Single	   cells	   studies	   based	   on	   these	   new	   techniques	   have	   provided	   additional	   evidence	   in	  
support	  of	  certain	  earlier	  results	  acquired	  at	  the	  population	  level	  via	  older	  methodologies,	  
but	  have	  also	  made	  original	  contributions	  to	  the	  understanding	  of	  the	  hematopoietic	  tree.	  
So	   far,	   these	   contributions	   have	   ranged	   from	   revealing	   significant	   heterogeneity	   in	  
apparently	  homogenous	  cell	   intermediates,	   to	  stimulating	  revisions	  to	  the	  topology	  of	   the	  
tree,	   to	   comparing	   the	   dynamics	   of	   naïve	   versus	   post-­‐transplantation	   hematopoiesis.	  We	  
begin	  by	  revisiting	  some	  of	  these	  discoveries.	  
	  
Heterogeneity	  in	  cell	  intermediates	  (stem	  cells	  and	  progenitors):	  
	  
Single	   cell	   methods	   are	   natural	   tools	   with	   which	   to	   study	   heterogeneity	   as	   they	   provide	  
information	   on	   each	   individual	   cell,	   in	   contrast	   to	   population	   averages	   which	   mask	  
individuality.	  It	  has	  long	  since	  been	  known	  that	  there	  is	  some	  heterogeneity	  in	  the	  potential	  
of	   cell	   intermediates,	   but	   high	   dimensional	   cell	   state	   data	   and	   barcoding	   methodologies	  
have	   revealed	  much	  more	   heterogeneity	   than	  was	   anticipated.	   An	   illustrative	   example	   of	  
this	  phenomenon	  is	  analysis	  of	  the	  murine	  CMP.	  Even	  though	  subsets	  of	  CMPs	  with	  unequal	  
lineage	  output	  in	  the	  megakaryocyte-­‐erythroid	  and	  granulocyte-­‐macrophage	  lineages	  were	  
reported	   [15–18],	  CMPs	  were	  still	   thought	   to	  be	  the	   last	  cell	   intermediate	  producing	  both	  
lineages.	  Evidence	  from	  massive	  scRNA-­‐seq	  combined	  with	   indexed	  FACS	  sorting	  [19],	  and	  
cellular	  barcoding	  [20]	  have	  shown	  that	  the	  murine	  CMPs	  are	  not	  a	  homogenous	  population	  
and	  that	  the	  majority	  of	  individual	  CMPs	  are	  not	  common	  to	  all	  the	  myeloid	  cells.	  Even	  the	  
existence	   of	   a	  minor	   population	   of	   truly	   common	  myeloid-­‐erythroid	   and	  megakaryocyte-­‐
erythroid	  progenitors	  is	  still	  to	  be	  ascertained	  as	  it	  is	  clear	  that	  the	  majority	  of	  cells	  classified	  
as	   CMPs	   are	   actually	   lineage-­‐restricted	   cells,	   as	   shown	   by	   histone	   modification	   mapping	  
[19].	  Similar	  results	  have	  been	  established	  in	  vitro	  for	  human	  CMPs	  [21].	  	  
	  
Heterogeneity	  has	  also	  been	  identified	  in	  other	  cell	   intermediates	  of	  the	  tree.	  Murine	  HSC	  
heterogeneity	   has	   been	   known	   for	   a	   long	   time	   (reviewed	   in[4]).	   Not	   surprisingly,	   after	  
transplantation	   barcoded	   HSCs	   were	   found	   to	   contribute	   to	   all	   the	   cell	   types	   analysed	  
(balanced),	  but	  some	  HSCs	  were	  uni-­‐outcome	  with	  output	  only	  in	  the	  myeloid	  or	  lymphoid	  
lineage	  [22].	  This	   recapitulated	  prior	   results	  obtained	  using	  single-­‐cell	   transfer	   [23,24]	  and	  
studies	   based	   on	   differential	   marker	   expression	   [25],	   as	   well	   as	   describing	   further	  
heterogeneity	  in	  the	  lymphoid-­‐biased	  HSC.	  Heterogeneity	  has	  since	  been	  identified	  in	  earlier	  
murine	  progenitors	  such	  as	  LMPPs	  and	  MPPs	  by	  barcoding	  [20,26],	  revealing	  similar	  results	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to	  those	  found	  in	  vitro	  for	  human	  cells	  [21],	  and	  by	  scRNA-­‐seq	  in	  other	  myeloid	  progenitors	  
downstream	  of	  CMPs	   in	  mouse	  and	  human	   [27,28].	  Note	   that	  heterogeneity	  has	  not	  only	  
been	   identified	   in	   progenitors	   and	   stem	   cells,	   but	   has	   also	   been	   revealed	   in	   terminally	  
differentiated	  hematopoietic	  cells.	  	  	  
This	   revelation	   of	   substantial	   heterogeneity	   provides	   significant	   challenges	   to	   our	   view	  of	  
the	   hematopoietic	   tree.	   First,	   it	   questions	   the	   existence	   of	   well-­‐defined	   discrete	  
hematopoietic	  intermediates	  throughout	  differentiation,	  as	  identified	  with	  external	  cellular	  
markers	  by	  FACS.	  Although	  scRNA-­‐seq	  data	  have	  provided	  predictive	  markers	  that	  for	  true	  
stem	  cells	  [29]	  and	  megakaryocyte-­‐erythroid	  committed	  progenitors	  [19]	  within	  the	  murine	  
HSC	   and	   CMP	   heterogeneous	   populations,	   respectively,	   they	   have	   yet	   to	   purify	  
homogeneous	  populations.	   Indeed,	   after	   transplantation,	   only	   a	   fraction	  of	   these	  purified	  
cells	   give	   the	   output	   predicted	   by	   RNA	   sequencing,	   suggesting	   enrichment	   rather	   than	   a	  
purification	   of	   the	   population.	   The	   difference	   in	   the	   actual	   output	   compared	   with	   the	  
prediction	   from	   RNA	   sequencing	   could	   result	   from	   effects	   of	   the	   niches	   where	   the	   cells	  
seed,	  or	  from	  partial	  reprogramming	  due	  to	  perturbation	  induced	  by	  the	  transplantation.	  It	  
is	  also	  possible,	  however,	  that	  the	  compartmentalization	  of	  cells	  into	  a	  collection	  of	  discrete	  
homogeneous	   hematopoietic	   intermediates	   provides	   for	   a	   poor	   description	   of	   cell	   state.	  
This	   idea	   has	  motivated	   computational	   work	   to	   avoid	   defining	   discrete	   intermediates,	   as	  
discussed	  later	  in	  this	  review.	  	  
Second,	   the	   existence	  of	   heterogeneous	   lineage	  output	   from	   stem	   cells,	   and	   to	   a	   greater	  
extent	   from	  MPPs,	   questions	   the	   source	   of	   this	   heterogeneity	   [30],	   as	   well	   as	   when	   and	  
where	  differentiation	  decisions	  are	  taken.	  It	  appears	  that	  choosing	  between	  the	  myeloid	  or	  
lymphoid	   lineage	   is	   not	   the	   first,	   primary	   delineation.	  More	   combinations	   of	   output	   from	  
MPPs	   than	   would	   be	   expected	   based	   on	   the	   classical	   hematopoietic	   tree	   have	   been	  
reported	   [20,26],	   calling	   for	   a	   revised	   version	   of	   the	   topology	   of	   the	   tree.	   The	   decisions	  
leading	  to	  this	  combination	  appear	  to	  be	  made	  at	  earlier	  stages	  than	  was	  initially	  thought,	  
mainly	  during	  the	  transition	  to	  the	  MPP	  population	  [31].	  	  
Topology	  of	  the	  hematopoietic	  tree	  
	  
Single	  cell	  studies	  are	  also	  questioning	  the	  shape	  of	  the	  tree.	  The	  canonical	  hematopoietic	  
tree	  (Fig	  1A),	  built	  mostly	  from	  FACS	  data	  and	  transplantation	  studies,	  describes	  a	  step-­‐by-­‐
step	   process	   of	   lineage	   commitment	   in	   which	   HSC	   self-­‐renew	   and	   generate	  multi-­‐potent	  
progenitors	  (MPP)	  that	  differentiate	  and	  produce	  all	  blood	  cells.	  This	  tree	  has	  already	  been	  
subjected	   to	   controversies	   over	   the	   years	   and	   numerous	   alternative	   models	   have	   been	  
proposed	   and	   reviewed	   elsewhere	   [32–34].	   Single	   cell	   studies	   have	   recently	   given	   some	  
insights	  on	  the	  topology	  of	  the	  tree.	  The	  classical	  tree	  is	  on	  more	  shaky	  ground	  than	  ever.	  	  
Cellular	  barcoding	  of	  murine	  LMPPs	  [26]	  and	  MPPs	  [20]	  has	  resulted	   in	  the	  observation	  of	  
large	   numbers	   of	   progenitors	   giving	   rise	   to	   dendritic	   cells	   without	   generating	   detectable	  
lymphoid	  and	  myeloid	  cells,	  suggesting	  a	  branching	  for	  DC	  that	  is	  distinct	  from	  the	  myeloid	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and	   lymphoid	   branches.	   Similarly,	   using	   IS	   barcoding	   on	   CD34+	   cells	   from	  macaques	   [35]	  
have	   shown	   that	   NK	   cells	   don’t	   share	   barcodes	  with	   lymphocytes	   and	  myeloid	   cells,	   and	  
could	  therefore	  originate	  from	  a	  separate	  branch.	  It	   is	  tempting	  to	  intuitively	  interpret	  the	  
presence	   of	   barcodes	   in	   one	   cell	   type	   as	   the	   indication	   of	   a	   separate	   branch,	   but	   both	  
detection	   and	   complex	   inferential	   issues	   can	   mislead	   our	   interpretation	   and	   suggest	  
prudence.	  Discussed	  further	  later,	  network	  inference	  methods	  have	  proposed	  the	  existence	  
of	   additional	   branches	   to	   the	   murine	   hematopoietic	   tree,	   such	   as	   a	   direct	   branch	   from	  
LMPPs	   to	   dendritic	   cells	   [36]	   (Fig	   1B).	   Making	   use	   of	   IS	   barcoding	   during	   human	   gene	  
therapy,	   Biasco	   et	   al.	   [12]	   have	   also	   proposed	   that	   NK	   cells	   develop	   independently	   of	  
lymphocytes.	   Even	   though	   not	   all	   the	   possible	   tree	   topologies	   were	   tested	   [12],	   they	  
concluded	   in	  favour	  of	  a	  tree	  where	   lymphoid	  progenitors	  retain	  a	  myeloid	  potential	   (also	  
called	   the	  myeloid	   bypass	  model	   [34],	   fig	   1C).	   Bearing	   in	  mind	   potential	   bias	   due	   to	   the	  
patient’s	  disease,	  these	  results	  offer	  further	  support	  for	  the	  idea	  that	  the	  lymphoid-­‐myeloid	  
segregation	  doesn’t	  occur	  in	  human	  [37].	  	  
	  
The	  heterogeneity	  in	  lineage	  output	  of	  murine	  HSC	  and	  MPP	  suggests	  that	  lineage	  decisions	  
occur	  early	   in	   the	  differentiation	  process.	  MPPs	   can	  be	  viewed	  as	  a	  population	  of	   lineage	  
committed	   progenitors	   with	   different	   combinations	   of	   lineage	   output	   (Fig	   1B).	   From	   this	  
data,	   it	   is	   still	   unclear	   what	   is	   the	   shape	   of	   the	   tree	   downstream	   of	   the	   MPP	   pool.	   We	  
envision	   that	   this	   time	   is	  a	  watershed	   for	   the	   field	  with	   fast	  developing	  experimental	  and	  
computational	  techniques,	  from	  which	  more	  exciting	  results	  on	  the	  topology	  of	  the	  tree	  will	  
come.	  	  	  
Dynamics	  of	  naïve	  and	  post-­‐transplantation	  hematopoiesis	  
	  
Single	   cell	   studies	   are	   bringing	   information	   not	   only	   about	   the	   topology	   of	   the	  
hematopoietic	   tree	   but	   also	   on	   the	   dynamical	   properties	   of	   the	   processes	   taking	   place	  
within	   it.	   Following	   transplantation,	   a	   small	   fraction	   of	   murine	   barcode-­‐labelled	   HSCs	  
contribute	   to	   hematopoietic	   output	   at	   a	   given	   time	   point	   after	   irradiation	   [26,38,39],	  
similarly	   to	   retroviral	   tagging	   studies	   [40–42].	   The	   cell	   types	   output	   by	   individual	   HSCs	  
changes	   little	  after	  3	  months	  post-­‐transfer,	  but	   their	  quantitative	   contribution	  varies	  over	  
time,	  with	  most	   of	   the	   HSCs	   expanding	   or	   declining	   [22].	   HSCs	   from	   old	  mice	   have	   been	  
observed	   to	   engraft	   as	   efficiently	   as	   HSCs	   from	   younger	   mice,	   contradicting	   previous	  
studies,	   although	   their	   cellular	   output	   was	   lower	   [22].	   Barcoded	   HSCs	   recovered	   from	  
individual	  bones	  were	  not	  uniformly	  distributed	  amongst	  them,	  and	  did	  not	  all	  contribute	  to	  
peripheral	  neutrophils	  [43].	  After	  granulocyte	  colony	  stimulating	  factor	  injection,	  however,	  
HSCs	   rapidly	   redistributed	   equally	   between	   bones,	   suggesting	   that	   HSCs	   are	   efficiently	  
recruited	  after	   inflammatory	   signals.	   In	  human	  and	  macaques	  a	   larger	  proportion	  of	  HSCs	  
lineage-­‐traced	   by	   integration	   sites	   is	   estimated	   to	   contribute	   to	   long-­‐term	   hematopoiesis	  
[12,44,45].	  After	  a	  first	  wave	  of	  short-­‐term	  progenitors	  post-­‐transplantation,	  hematopoiesis	  
is	  maintained	  by	  progenitors	  with	  a	  balanced	  myelo-­‐lymphoid	  output	  at	  steady	  state.	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Using	  transposon	  barcoding,	  Sun	  et	  al	  [14]	  have	  tagged	  individual	  murine	  cells	  in	  situ.	  At	  the	  
time	  of	   induction,	  a	   fraction	  of	  the	  cells	  are	   labelled	  non-­‐specifically,	   i.e.	   independently	  of	  
their	   cell	   state.	  By	  using	   this	   system,	   it	  has	  been	  shown	   that	   thousand	  of	  different	   clones	  
maintain	   long-­‐term	   granulopoiesis	   sequentially.	   Those	   clones	   were	   present	  mostly	   in	   the	  
MPPs	   and	   not	   in	   the	   HSCs,	   leading	   the	   authors	   to	   conclude	   that	   MPPs	   are	   the	   main	  
contributor	  of	   hematopoiesis	   in	   steady	   state,	   even	   if	   limits	   of	   detection	   cannot	   exclude	   a	  
contribution	   from	   HSCs.	   Together	   with	   the	   results	   from	   lineage	   tracing	   studies	   at	   the	  
population	   level	   [46],	   this	   result	   clearly	   contrasts	   with	   the	   situation	   post-­‐transplantation	  
where	   only	   a	   few	   stable	   HSC	   contribute	   to	   hematopoiesis.	   These	   results	   show	   that	   the	  
dynamics	   of	   normal	   hematopoiesis	   are	   different	   than	   those	   after	   transplantation.	   More	  
studies	   need	   to	   be	   done	   to	   infer	   the	   dynamics	   downstream	  of	  HSC	   in	   the	   tree	   in	   normal	  
conditions.	  
Single	   cell	   studies	   have	   made	   important	   contributions	   to	   the	   understanding	   of	   the	  
hematopoietic	   tree,	   but	   these	   deductions	   are	   contingent	   on	   both	   biological	   and	   data-­‐
analytic	  assumptions	  that	  we	  wish	  to	  make	  explicit.	  In	  doing	  so,	  we	  hope	  to	  make	  clear	  what	  
we	  see	  as	  potential	  opportunities	  for	  both	  experimental	  and	  theoretical	  development,	  and	  
revisit	  our	  notion	  of	  appropriate	  quantitative	  descriptions	  of	  the	  hematopoietic	  lineage.	  
	  
Experimental	  abilities	  and	  limitations	  of	  recent	  single	  cell	  methods	  used	  for	  hematopoiesis	  	  
	  
We	  have	  divided	   these	  methods	   into	   two	  categories:	   those	   that	  provide	  high	  dimensional	  
measurement	  of	  single	  cell	  state	  (massively	  parallel	  scRNA-­‐seq,	  mass	  cytometry);	  and	  those	  
that	   enable	   in	   vivo	   lineage	   tracing	   of	   multiple	   initial	   cells,	   referred	   to	   here	   as	   barcoding	  
(integration	   site	   barcoding,	   cellular	   barcoding,	   transposon	   barcoding).	   An	   important	  
distinction	  between	  the	  methods	  is	  whether	  they	  can	  measure	  the	  in	  vivo	  outcome	  of	  cells,	  
meaning	  what	  the	  cells	  are	  actually	  becoming	  during	  differentiation.	  Note	  that	  none	  of	  the	  
methods	  discussed	  here	  can	  measure	  the	  potential	  of	  what	  a	  cell	  can	  do.	  	  
	  
Many	   of	   the	   technical	   aspects,	   technical	   adaptations,	   data	   processing	   and	   so	   forth,	   have	  
been	  reviewed	  elsewhere	  [10,13].	  Thus	  here	  we	  focus	  on	  outlining	  differences	  between	  the	  
techniques	  that	  have	  an	  impact	  on	  biological	  conclusions	  for	  the	  hematopoietic	  tree	  (table	  
1).	  
	  
As	  a	  first	  comment,	  we	  would	  like	  to	  point	  out	  that	  unlike	  FACS	  analysis,	  all	  these	  methods	  
are	   destructive	   for	   the	   cells	   and	   hence	   forbid	   their	   use	   for	   functional	   assays	   after	   their	  
characterization.	  All	  methods	  involving	  sequencing	  (scRNA-­‐seq,	  barcoding)	  require	  the	  cells	  
to	   be	   lysed,	   and	   mass	   cytometry	   includes	   cell	   destruction	   in	   its	   processing	   pipeline.	   In	  
addition,	   the	   methods	   generally	   provide	   snapshot	   measurements	   (scRNA-­‐seq,	   mass	  
cytometry	  and	  barcoding),	  with	  the	  exception	  of	  barcoding	  when	  sequential	  blood	  sample	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are	   taken.	   As	   hematopoiesis	   is	   a	   dynamic	   process,	   snapshot	   measurements	   are	   a	   major	  
limitation	  to	  be	  contrasted	  with	  live	  imaging	  studies.	  	  
	  
All	  of	  these	  methods	  have	  been	  applied	  to	  study	  the	  hematopoietic	  tree	   in	  mice	  and,	  to	  a	  
lesser	   extent,	   in	   monkeys	   and	   zebrafish	   [47].	   Only	   scRNA-­‐seq,	   mass	   cytometry	   and	  
integration	  site	  barcoding	  have	  been,	  and	  can	  presently	  be,	  used	  for	  humans.	  	  	  
	  
High	  dimensional	  measurements	  of	  single	  cell	  state	  	  
	  
In	   scRNA	   sequencing,	   cells	   are	   directly	   extracted	   from	   tissues	   without	   further	   ex-­‐vivo	  
manipulation.	  Cells	  require	  no	  pre-­‐sorting,	  avoiding	  categorization	  prior	  to	  measurement.	  In	  
addition,	   scRNA-­‐seq	   can	   be	   coupled	   with	   index	   sorting	   for	   correlation	   with	   surface	  
phenotypic	  expression	  by	  FACS	  [19,29].	  Compared	  with	  genome	  sequencing,	  scRNA-­‐seq	  has	  
the	   advantage	   that	   it	   provides	   a	   characterization	   of	   the	   part	   of	   the	   genome	   that	   is	  
expressed,	   but	   only	   offers	   an	   incomplete	   picture	   due	   to	   limitations	   in	   read	   coverage.	  
Thousands	   of	   single	   cells	   have	   been	   analysed	   in	   the	   most	   recent	   versions	   of	   these	  
techniques	  [10].	  By	  measuring	  the	  whole	  expressome,	  or	  hundreds	  of	  targeted	  genes,	  one	  
expects	   to	  extract	   a	  higher	  dimensional	   characterization	  of	   the	   cell	   state	   than	   is	   available	  
with	  traditional	  surface	  phenotyping	  expression	  methods	  such	  as	  FACS.	  	  
	  
Mass	  cytometry	  offers	  a	  higher	  dimensional	  characterization	  than	  FACS,	  with	  the	  limitation	  
that	   cells	   cannot	   be	   re-­‐used	   after	   analysis.	   In	   this	   method,	   cells	   are	   analysed	   just	   after	  
extraction	   from	   tissues	  without	   further	   ex-­‐vivo	  manipulation.	  Mass	   cytometry	   can	   readily	  
interrogate	  millions	  of	  cells	  and	  informs	  us	  of	  the	  surface	  phenotypic	  expression	  of	  cells	  as	  
well	   as	   aspects	   of	   their	   intracellular	   expression.	   Neither	   scRNA-­‐seq	   nor	   mass	   cytometry	  
alone	  provide	  information	  on	  the	  potential	  of	  cells	  or	  their	  consequent	  outcome	  in	  vivo.	  By	  
making	  assumptions	  on	  commitment	  mechanisms,	  both	  scRNA-­‐seq	  and	  mass	  cytometry	  can	  





Cellular	   barcoding	   is	   unbiased	   as	   its	   expression	   is	   not	   conditioned	  on	   the	   expression	  of	   a	  
particular	   gene	   unlike	   other	   lineage	   tracing.	   It	   can	   follow	   hundreds	   of	   single	   cell	  
simultaneously	  in	  vivo.	  Cellular	  barcoding	  involves	  manipulation	  of	  cells	  ex-­‐vivo	  before	  their	  
re-­‐injection,	  which	  can	  affect	  their	  differentiation.	  These	  manipulations	  consist	  in	  extracting	  
the	  progenitor	  or	  stem	  cells	  of	   interest	   from	  the	  tissue,	   labelling	  them	  by	   infection	  with	  a	  
retro	  or	  a	   lentivirus	   for	   few	  hours	   in	   vitro.	   In	  addition,	   the	   integration	  of	   the	   tag	   into	   the	  
genome	  could	  also	  affect	   the	  differentiation	  of	   the	  cell,	  even	   if	  no	  differentiation	  bias	  has	  
been	   observed	   when	   integration	   site	   were	   analysed	   [39].	   Another	   limitation	   is	   that	   the	  
barcoded	  progenitor	  or	  stem	  cells,	  as	  well	  as	  the	  final	  differentiated	  cells,	  need	  to	  be	  sorted	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by	  FACS,	  and	  this	  categorization	  needs	  to	  be	  decided	  in	  advance	  of	  the	  analysis.	  In	  contrast	  
with	   scRNA-­‐seq,	   the	   read	   coverage	   is	   generally	   good,	   especially	   if	   a	   reference	   library	   is	  
available	   [13].	   Cellular	   barcoding	  measures	   the	   output	   of	   individual	   cells,	   in	   other	   words	  
what	  the	  cells	  do	  but	  it	  cannot	  measure	  what	  cells	  can	  do.	  	  
	  
Most	   of	   the	   abilities	   and	   limitations	   of	   cellular	   barcoding	   also	   apply	   to	   Integration	   Site	  
barcoding	  as	  it	  too	  uses	  viral	  labelling.	  The	  main	  difference	  is	  the	  read	  out	  of	  the	  barcode.	  IS	  
barcoding	  needs	  to	  identify	  the	  DNA	  sequence	  outside	  of	  the	  integration	  site,	  which	  is	  more	  
difficult	  than	  performing	  the	  specific	  nested	  PCR	  in	  cellular	  barcoding.	  Using	  linear	  PCR	  and	  
restriction	  enzyme	  solve	  this	  challenge	  but	  result	  in	  a	  lower	  read	  coverage	  and	  causes	  some	  
detection	  issues.	  	  
	  
Transposon	   barcoding	   labels	   cells	   in	   situ,	   avoiding	   the	   ex-­‐vivo	   manipulation	   typical	   to	  
barcoding	  methods	  and	  therefore	  allowing	  the	  study	  of	  naïve	  murine	  hematopoiesis	  [14].	  In	  
the	   current	   published	   system	   all	   the	   cells,	   irrespective	   of	   their	   cell	   type,	   are	   potentially	  
labeled,	  which	   complicates	   the	   subsequent	  analysis.	  One	   can	   readily	   imagine	   crossing	   the	  
transposon	   barcoding	   mouse	   to	   strains	   in	   which	   the	   CRE	   expression	   is	   driven	   by	   genes	  
specific	   to	   certain	   progenitors	   or	   stem	   cells.	   Like	   other	   barcoding	   techniques,	   transposon	  
barcoding	   requires	   the	   sorting	   by	   FACS	   of	   the	   differentiated	   cells,	   but	   avoids	   the	   initial	  
sorting	   step	   of	   progenitors	   and	   stem	   cells.	   Even	   if	   it	   was	   reported	   to	   be	   minor	   [14],	  
transposition	  events	  occurring	  outside	  of	  the	  induction	  period	  can	  be	  a	  confounding	  factor	  
to	  the	  lineage	  analysis.	  Transposon	  barcoding	  uses	  the	  integration	  site	  has	  a	  read	  out	  for	  the	  
tag	  and	  therefore	  suffer	  from	  the	  same	  limitation	  in	  term	  of	  read	  coverage	  as	  IS	  barcoding.	  
An	   attempt	   to	   overcome	   this	   limitation	   in	   read	   coverage	   has	   resulted	   in	   a	   lower	   cell	  
detection	  limit,	  but	  also	  in	  the	  loss	  of	  the	  quantification	  information	  per	  tag	  [14].	  	  
	  
Making	  sense	  of	  the	  data:	  the	  modelling	  and	  the	  inference	  methods	  (table	  2)	  
These	   recent	   single	   cell	   techniques	  produce	   large	  volumes	  of	  data	  with	   their	  own	  distinct	  
complexities	   As	   a	   result,	   they	   require	   the	   development	   and	   application	   of	   analytic	  
methodologies	   for	   their	   interrogation.	   Each	   experimental	   technique	   produces	   entirely	  
distinct	   output	   and	   every	  methodology	   introduces	   its	   own	   unique	   challenges	   in	   terms	   of	  
sampling	  depth,	  experimental	  noise,	  and	  data	  filtering.	  Despite	  the	  specificities	  needed	  for	  
the	  processing	  of	  each	  data	  source;	  the	  core	  of	  the	  data	  analysis	   techniques	  used	   is	  often	  
detail-­‐agnostic,	  with	  fundamental	  principles	  being	  similar,	  which	  we	  now	  describe.	  	  
	  
High-­‐dimensional	  single	  cell	  state	  data	  
For	  inference	  of	  the	  hematopoietic	  tree,	  there	  is	  a	  one	  common	  difficulty	  to	  all	  of	  the	  high	  
dimensional	   data	   sources.	   While	   the	   tree	   summarizes	   development	   without	   explicit	  
reference	  to	  time,	  hematopoiesis	  is	  a	  dynamic	  process	  in	  time	  and	  space.	  In	  the	  absence	  of	  
time-­‐course	  data,	   inferences	  from	  high	  dimensional	  data	  (scRNA-­‐seq,	  mass	  cytometry)	  are	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made	  using	  implicit	  or	  explicit	  notions	  of	  pseudo-­‐time.	  	  
As	  a	  single-­‐time	  snapshot	  captures	  cells	  at	  different	  stages	  of	  the	  development	  process,	  the	  
fundamental	  premise	  of	  pseudo-­‐time	  is	  that	  temporal	  development	  paths	  through	  these	  cell	  
states	  can	  be	  inferred.	  Irrespective	  of	  the	  data	  source,	  the	  data	  analysis	  assumes	  that	  cells	  
with	  the	  same	  potential	  cluster	  together,	  and	  that	  transitions	  from	  cells	  of	  one	  type	  to	  more	  
committed	   types	   are	   marked	   by	   continuous	   changes	   in	   internal	   state	   between	   dense	  
clusters.	   The	   latter	   property	   is	   then	   used	   to	   infer	   a	   differentiation	   tree	   by	   assuming	   that	  
clusters	   of	   cells	   whose	  measured	   state	   are	   close	   to	   each	   other	   correspond	   to	   sequential	  
differentiation	  state.	  	  
In	  all	  the	  tree	  inference	  methods,	  commitment	  is	  assumed	  to	  be	  a	  smooth	  function	  of	  state,	  
with	   areas	   of	   high	   density	   anticipated	   to	   correspond	   to	   cell	   intermediates	   such	   as	   the	  
previously	   phenotypically-­‐identified	   cell	   types.	   Essential	   to	   that	   supposition	   is	   that	  
differentiation	   does	   not	   lead	   to	   abrupt	   changes	   in	   internal	   cell	   state,	   that	   patterns	   that	  
appear	   in	   early	   progenitors	   do	   not	   reappear	   in	  more	   committed	   cell	   types,	   and	   that	   cell	  
types	  that	  are	  distant	  in	  the	  putative	  tree	  are	  dissimilar	  in	  terms	  of	  their	  cell	  content.	  There	  
are	   few	   experimental	   studies	   on	   this	   topic,	   but	   those	   that	   have	   been	   reported	   suggest	  
circumspection	   with	   regards	   theses	   assumptions.	   In	   the	   1980s,	   analysis	   of	   hundreds	   of	  
murine	  progenitor	  established	  that	  commitment	  to	  a	  single	  lineage	  could	  occur	  slowly	  and	  
in	   a	   stepwise	  manner	   over	   generations,	   or	   within	   just	   one	   generation	   [48–50].	   Similarly,	  
single	  cell	  transplantation	  of	  the	  two	  offspring	  of	  an	  individual	  HSC	  after	  one	  division	  in	  vitro	  
suggests	  that	  differentiation	  can	  occur	  in	  one	  division	  [34].	  Using	  small	  populations	  of	  cells,	  
Lare-­‐Astiaso.D.	  et	  al	  [51]	  have	  shown	  that	  most	  of	  the	  genes	  in	  multi-­‐potent	  cells	  transition	  
from	  an	  open	  chromatin	   state	   to	  a	   compacted	  chromatin	   state	   in	  differentiated	  cells,	  but	  
some	  genes	  follow	  a	  different	  pattern	  with	  de	  novo	  enhancement	  during	  differentiation.	  	  
Based	   on	   these	   presumptions	   and	  motivated	   by	   various	   data	   sources,	   several	   inferential	  
methodologies	   have	   been	   developed.	   All	   begin	   with	   a	   biologically	   and	   experimentally	  
informed	   denoising	   of	   the	   data.	   As	   existing	   evidence	   strongly	   indicates	   that	   cell	   numbers	  
become	   more	   numerous	   as	   cells	   lose	   potential,	   this	   pre-­‐processing	   typically	   involves	   a	  
significant	  renormalization	  of	  the	  data	  so	  that	  more	  rarely	  sampled	  cells	  are	  treated	  as	  being	  
as	   important	  as	  highly	  sampled	  ones	   in	   the	  analysis	   that	   follows.	  This	  pre-­‐processing	   is	  an	  
important	  aspect	  of	  the	  treatment	  of	  the	  data	  and	  care	  is	  placed	  on	  informing	  it.	  
After	   experiment-­‐technique	   specific	   data	   filtering,	   the	   first	   step	   in	   all	   analyses	   of	   high	  
dimensional	  data	   is	  dimension	   reduction.	  This	  aims	   to	  provide	  substantially	  more	  succinct	  
representations	  of	  the	  data	  with	  minimal	  loss	  of	  information.	  After	  dimension	  reduction,	  the	  
resulting	  data	  is	  substantially	  smaller	  and	  so	  more	  suitable	  for	  computationally	  testing	  and	  
comparing	  hypotheses.	  As	  inference	  is	  performed	  on	  the	  dimension-­‐reduced	  data,	  the	  form	  
of	  reduction	  can	  have	  a	  substantial	  impact	  on	  subsequent	  deductions.	  	  
Here	  we	  discuss	  methods	  based	  on	  a	  distinction	  between	  two	  types	  of	  dimension	  reduction:	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clustering,	  which	  dramatically	  reduces	  the	  data	  to	  a	  finite	  collection	  of	  states;	  and	  a	  variety	  
of	  non-­‐clustered	  approaches	  that	  effectively	  project	   the	  data	  onto	  subspaces	  that	  capture	  
the	  majority	  of	  the	  latent	  information.	  The	  reason	  for	  making	  this	  distinction	  is	  that	  there	  is	  
a	   significant	  delineation	   in	   the	  machine	   learning	   approaches	   taken	  based	  on	  whether	   the	  
data	  is	  first	  clustered.	  
Clustered	  data	  
Clustering	  is	  an	  unsupervised	  learning	  task	  that	  attempts	  to	  group	  similar	  objects	  based	  on	  	  	  
similarity	   defined	   by	   a	   distance	   measure.	   It	   comes	   in	   two	   forms:	   flat,	   or	   partitional,	  
clustering;	   and	   hierarchical	   clustering.	   In	   flat	   clustering,	   one	   determines	   in	   advance	   how	  
many	  cell	  types	  one	  is	  looking	  for	  and	  a	  randomized	  algorithm	  then	  partitions	  the	  data	  into	  
that	  many	   groups	   in	   a	  way	   that	   attempts	   to	  maximise	   the	   similarity	  within	   a	   group,	   and	  
minimize	   the	   similarity	   between	   groups.	   Clearly	   the	   outcome	   of	   this	   process	   is	   heavily	  
dependent	  on	  how	  many	  clusters	  one	  seeks.	  	  
Hierarchical	   clustering	   provides	   a	   tree	   of	   nested	   groupings	   and	   comes	   in	   two	   forms.	   In	  
agglomerative	   hierarchical	   clustering,	   each	   data	   point	   starts	   out	   in	   its	   own	   cluster	   and	  
clusters	   are	   merged	   sequential	   way	   based	   on	   their	   similarity	   to	   form	   a	   hierarchy	   of	  
relationships.	   In	   divisive	   hierarchical	   clustering	   the	   data	   all	   starts	   in	   one	   cluster,	   which	   is	  
then	  sequentially	  broken	  up	  to	  form	  a	  distinct	  hierarchy	  of	  nested	  relationships.	  After	  these	  
processes,	  if	  the	  clustered	  data	  is	  to	  be	  analysed	  further,	  one	  must	  decide	  at	  what	  level	  the	  
clustering	  is	  to	  be	  considered,	  and	  so	  as	  with	  flat	  clustering	  the	  number	  of	  groups	  of	  interest	  
must	  be	  determined.	  
From	  this	  discretised	  data,	  a	  tree	  is	  typically	  then	  inferred	  by	  the	  adoption	  and	  adaptation	  of	  
phylogenetic	  approaches	  developed	  for	  evolutionary	  biology.	  The	  following	  provides	  a	  non-­‐
exhaustive	   set	   of	   examples	   of	   these	   approaches	   applied	   to	   clustered	   data	   from	   distinct	  
sources	  of	  high	  dimensional	  single	  cell	  methods	  applied	  to	  hematopoiesis.	  
For	  high-­‐volume	  mass	  cytometry	  data,	  Qui	  et	  al,	  and	  Bendall	  et	  al	  [11,52]	  developed	  an	  end-­‐
to-­‐end	   algorithm	   called	   SPADE	   (Spanning-­‐tree	   Progression	   Analysis	   of	   Density-­‐Normalized	  
Events)	   based	   on	   hierarchical	   clustering	   of	   down-­‐sampled	   data	   followed	   by	   the	  
determination	  of	  a	  minimum	  spanning	  tree.	  That	  is,	  the	  tree	  which	  links	  all	  the	  clusters	  but	  
has	   the	   shortest	   total	   distance	   along	   its	   links,	   with	   the	   anzats	   being	   that	   differentiation	  
corresponds	  to	  a	  sequence	  of	  small	  changes	  in	  state.	  For	  massively	  parallel	  scRNA-­‐seq	  data,	  
Paul	   et	   al	   [19]	   clustered	   down-­‐sampled	   data,	   with	   subsequent	   manual	   curation	   for	   the	  
specific	  identification	  of	  small	  clusters.	  Index	  sorting	  flow	  cytometry	  is	  used	  to	  compare	  the	  
resulting	  groups	  with	  cell	  surface	  marker	  defined	  cell	  types.	  
With	  the	  ultimate	  intent	  of	  providing	  a	  method	  to	  identify	  stem	  cells	  from	  scRNA-­‐seq	  data,	  
Grun	  et	   al.	   [53]	   created	   a	  method	   for	   tree	   inference	   and	  applied	   it	   to	  data	   from	   systems	  
include	  murine	  hematopoiesis.	  Their	  approach	  is	  to	  use	  Pearson	  correlation	  as	  a	  measure	  of	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similarity	  and	  to	  perform	  flat	  clustering	  using	  k-­‐medoids,	  a	  variant	  of	  the	  classical	  k-­‐means	  
clustering	  that	  allows	  non-­‐Euclidean	  distances	  and	  identifies	  cluster	  centres	  with	  a	  member	  
of	  the	  dataset.	  Links	  are	  drawn	  between	  all	  pairs	  of	  cluster	  centres	  and	  each	  cell	  in	  the	  data	  
is	  projected	  onto	  the	  link	  that	  it	  lies	  closest	  to.	  The	  network	  of	  connections	  between	  cluster	  
centres	  is	  then	  pruned	  by	  assuming	  that	  if	  a	  link	  has	  substantially	  more	  cells	  assigned	  to	  it	  
than	  one	  would	  expect	  by	  chance,	  it	  corresponds	  to	  a	  differentiation	  pathway.	  Identification	  
of	  the	  root	  node	  of	  the	  network,	  the	  stem	  cell,	  relies	  on	  the	  biological	  assumption	  that	  the	  
transcriptome	   of	   a	  multi-­‐potent	   cell	   is	  more	   uniform	   than	   that	   of	   a	   differentiated	   cell.	   A	  
combination	   of	   the	   median	   empirical	   Shannon	   entropy	   of	   a	   cluster,	   as	   a	   measure	   of	  
divergence	  from	  uniformity,	  along	  with	  the	  number	  of	  links	  is	  combined	  into	  a	  metric	  from	  
which	  the	  putative	  root	  is	  determined.	  
Motivated	  by	  general	  issues	  in	  lineage	  inference	  from	  single	  cell	  data,	  Giecold	  et	  al	  [54]	  have	  
introduced	  a	  suite	  of	  publically	  available	  code	  called	  ECLAIR	  (Ensemble	  Cell	  Lineage	  Analysis	  
with	   Improved	  Robustness).	   The	  basic	  principle	  of	  ensemble	   learning	   is	   that	   if	   there	   is	  no	  
reason	  to	  believe	  any	  one	  method	  will	  outperform	  any	  other,	   then	   integrating	  deductions	  
across	  several	  of	  them	  is	  a	  good	  strategy.	  In	  this	  instance,	  the	  data	  is	  sampled	  using	  either	  
uniform	   or	   density	   dependent	   sampling,	   and	   then	   clustered	  with	   different	  methods.	   The	  
maximum	   average	   normalised	  mutual	   information	   of	   the	   clusters	   is	   evaluated	   by	   several	  
clustering	   methods,	   with	   the	   best	   selected	   for	   further	   processing.	   A	   complete	   weighted	  
graph	   is	   formed	   amongst	   the	   consensus	   clusters,	   with	   edge	   weights	   corresponding	   to	  
Euclidean	   distances,	   and	   a	   minimum	   spanning	   tree	   is	   inferred.	   The	   approach	   has	   been	  
applied	   to	   hematopoietic	   data,	   but	   primarily	   for	   purposes	   of	   demonstrating	   its	   abilities	  
rather	   than	   for	   the	   deduction	   of	   new	   biological	   knowledge.	   When	   applied	   to	   mass	  
spectrometry	  data	  [11],	  improved	  robustness	  in	  tree	  reconstruction	  over	  SPADE	  is	  shown.	  In	  
order	  to	  apply	  the	  approach	  to	  scRNA-­‐seq	  data	  taken	  from	  [19],	  the	  authors	  performed	  an	  
additional	   initial	  dimensional	   reduction	  step	  on	  the	  data	  by	  Principal	  Component	  Analysis.	  
Applied	   to	   the	   resulting	   dimensionally	   reduced	   data,	   ECLAIR	   analysis	   largely	   recapitulates	  
the	  findings	  of	  the	  original	  paper.	  
Non-­‐clustered	  data	  
The	   alternative	   approach	   to	   clustering	   is	   to	   begin	   with	   the	   non-­‐discretised	   data	   and	   to	  
essentially	  project	  it	  onto	  a	  lower	  dimensional	  space,	  then	  simultaneously	  identifying	  areas	  
of	  density	  with	  links	  between	  them.	  While	  there	  are	  some	  standard	  techniques	  to	  achieve	  
this	   dimensional	   reduction,	   such	   as	   Independent	   Component	   Analysis,	  which	   attempts	   to	  
project	   the	   data	   onto	   a	   smaller	   number	   of	   statistically	   independent	   co-­‐ordinates,	   several	  
distinct	  methodologies	  have	  been	  employed	  in	  the	  study	  of	  single	  cell	  hematopoietic	  data.	  
Judicious	  pre-­‐processing	  of	  the	  data	  is	  still	  required	  to	  account	  for	  the	  known	  rarity	  of	  more	  
multi-­‐potent	  progenitors,	  but	  the	  dimension	  reduction	  performed	  is	  lesser.	  For	  inference	  of	  
paths,	   the	  post	   reduction	  data	   typically	  necessitates	  methodologies	   that	   are	  distinct	   from	  
those	  used	  in	  phylogenetics.	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For	   illustration,	   again	  we	   provide	   a	   non-­‐exhaustive	   collection	   of	   representative	  work.	   For	  
scRNA-­‐seq	  data,	  Trapnell	  et	  al	  [55]	  introduced	  an	  unsupervised	  learning	  algorithm,	  Monocle,	  
that	   takes	   the	   raw	   data	   and	   assumes	   that	   transitions	   from	   progenitor	   to	   one	   of	   several	  
committed	  cell	  types	  is	  marked	  by	  a	  smooth	  shift	  in	  transcriptional	  state.	  Rather	  than	  using	  
clustering,	   less	   substantial	   state	   space	   reduction	   is	   achieved	   by	   independent	   component	  
analysis.	   Monocle	   then	   determines	   a	   minimum	   spanning	   tree	   on	   the	   resulting	   low-­‐
dimensional	  projection	  of	  cell	   state.	  Motivated	  by	  mass	  cytometry	  data,	  Bendall	  et	  al	   [56]	  
develop	  an	  algorithm	  called	  Wanderlust	  that	  aims	  to	  find	  single	  paths,	  rather	  than	  branching	  
trees,	  through	  high	  dimensional	  data.	  Dimensional	  reduction	  is	  achieved	  by	  considering	  the	  
cells	   as	   vertices,	   selecting	   a	   collection	   of	   cells	   uniformly	   at	   random	   as	   waypoints,	   and	  
constructing,	   for	   some	   fixed	   number	   of	   neighbours,	   random	   k-­‐nearest	   neighbour	   graphs	  
through	   which	   biased	   random	   walks	   from	   a	   source	   to	   destination	   are	   considered.	   The	  
output	  trajectory	  is	  set	  to	  the	  average	  over	  an	  ensemble	  of	  graph	  trajectories.	  With	  general	  
high-­‐dimensional	   single-­‐cell	   data	   in	   mind,	   Haghverdi	   et	   al	   [57]	   have	   designed	   a	   method	  
based	   on	   a	   well-­‐established	   machine	   learning	   technique	   called	   diffusion	   maps	   [58].	   The	  
essential	   underlying	   idea	   is	   again	   to	   consider	   the	   relatedness	   of	   cells	   as	   determined	   by	   a	  
random	   walk	   across	   neighbours	   within	   a	   given	   distance,	   which	   provides	   the	   dimension	  
reduction,	  with	  cell	  densities	  determining	  drift	  directions.	  Meta-­‐stable	  states,	  i.e.	  collections	  
of	  cells	  where	  the	  random	  walker	  spends	  long	  periods	  of	  time	  circulating	  before	  moving	  on,	  
are	   then	   identified	   as	   groups,	   with	   the	   most	   likely	   trajectories	   between	   them	   indicating	  
differentiation	  transitions.	  An	  advantage	  of	  this	  diffusion	  map	  view	  is	  that	  the	  identifications	  
of	   groups	  and	  connections	  between	   them	  can	  be	  achieved	  directly	  by	   spectral	   analysis	  of	  
the	  Markov	   chain	   described	   by	   the	   random	   walk,	   without	   resorting	   to	  Monte	   Carlo	   (i.e.	  
stochastic	   simulation)	   methods,	   and	   general	   properties	   of	   the	   algorithm	   can	   be	  
mathematically	  established.	  
As	  a	  general	  comment	  on	  high	  dimensional	  data,	  there	  is	  no	  biological	  reason	  to	  believe,	  a	  
priori,	   that	   any	  of	   the	  machine	   learning	  and	  phylogenetic	   inference	  approaches	  discussed	  
here	  is	  superior,	  though	  minimalistic	  data	  reduction	  before	  inference	  holds	  intrinsic	  appeal.	  
While	  the	  pre-­‐processing	  steps	  of	  each	  of	  the	  above	  methods	  are	  all	  data-­‐type	  dependent,	  
the	  fundamental	  principles	  guiding	  the	  analysis	  of	  the	  post-­‐processed	  data	  are	  the	  same	  and	  
the	  methods	  could	  each	  be	  adapted	  for	  data	  of	  each	  type.	  Of	  note,	  all	  the	  approaches	  make	  
a	   common	   assumption	   that	   commitment	   is	   a	   smooth	   function	   of	   state,	   while	   the	   other	  
suppositions	   that	   distinguish	   the	   different	   methods	   are	   driven	   more	   by	   questions	   of	  
computational	   feasibility,	   the	  presence	  of	   an	   existing	   formalism	  and	   so	   forth,	   rather	   than	  
any	  biological	   reasons.	  Finally,	  one	  should	  think	  of	   the	   inferred	  tree	  as	  a	  hypothesis	   to	  be	  
confirmed	   by	   other	   means,	   rather	   than	   as	   a	   definitive	   deduction.	   In	   particular,	   the	  
assumption	  of	  continuous	  commitment	  needs	  further	  biological	  clarification.	  	  
Barcoding	  data	  
To	   the	   best	   of	   our	   knowledge,	   the	   development	   of	   data	   analytic	   approaches	   for	   lineage	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tracing	  experiments	  has	  been	  more	   limited,	  with	  most	  papers	   reporting	  observations	  and	  
deductions	  directly	  from	  data.	  This	  may,	  in	  part,	  be	  the	  case	  due	  to	  the	  natural	  applicability	  
of	  developments	  from	  existing	  clustering,	  phylogenetic	  and	  machine	  learning	  approaches	  to	  
high	  dimensional	  data,	  while	  inference	  from	  lineage	  data	  require	  distinctive	  techniques.	  	  
Motivated	  by	  cellular	  barcoding	  data	  from	  non-­‐self-­‐renewing	  cells,	  we	  developed	  a	  method	  
to	  determine	  if	  a	  network	  is	  consistent	  with	  the	  data	  [36].	  It	  is	  assumed	  that	  barcoded	  cells	  
begin	   with	   the	   potential	   to	   make	   a	   collection	   of	   phenotypically	   defined	   terminally	  
differentiated	   cell	   types	  and	   there	   is	   an	  unknown	  directed	  network,	  which	  need	  not	  be	  a	  
tree,	   of	   cell	   intermediaries	  with	   restricted	   potential.	   Cells	   are	   assumed	   to	   proliferate	   and	  
differentiate	  stochastically	  in	  the	  network	  independently	  of	  their	  lineage	  and	  independently	  
of	  each	  other	  until	  a	  combination	  of	  terminally	  differentiated	  cells	  is	  produced.	  Thus	  initially	  
barcoded	   transient	   progenitors	   ultimately	   produce	   a	   probabilistic	   pattern	   of	   terminally	  
differentiated	   barcoded	   cell	   combinations	   that	   can,	   using	   results	   from	   cascade	   processes	  
(Good,	  1949),	  be	  determined	  explicitly	  as	  a	  function	  of	  the	  network’s	  parameterization.	  For	  
each	   putative	   network,	   the	   best	   fit	   proliferation	   and	   differentiation	   probabilities	   are	  
determined	  numerically,	  and	  statistical	  consistency	  with	  the	  data	  checked.	  Based	  on	  those	  
assumptions,	  the	  method	  enables	  the	  statistical	  rejection	  of	  proposed	  networks.	  	  
For	   non-­‐transient	   populations,	   assuming	   sequential	   blood	   samples	   of	   the	   output	   from	   IS	  
barcoded	  progenitors,	  Goyal	  et	  al	   [59]	  developed	  a	  mathematical	  model	  with	  a	   simplified	  
network	   consisting	   of	   HSCs,	   pooled	   transit-­‐amplifying	   progenitor	   cells,	   and	   fully	  
differentiated	  nucleated	  blood	  cells.	  The	  aim	  is	  not	  to	  challenge	  the	  hematopoietic	  tree	  or	  
the	  sequential	  output	  from	  individual	  clones,	  but	  to	  better	  understand	  the	  evolution	  of	  the	  
clone-­‐size	  distribution.	  	  
Also	  motivated	  by	   long	   term,	   repeat	  blood	   samples,	   IS	  barcoding	  data,	   though	   in	  humans	  
rather	  than	  macaques,	  Biasco	  et.	  Al	  [12]	  used	  a	  suite	  of	  techniques	  to	  interrogate	  their	  data.	  
By	  assigning	  a	  Bayesian	  network	  to	  each,	  the	  relative	  ability	  of	  two	  putative	  hematopoietic	  
hierarchies	  to	  describe	  the	  data	  was	  first	  tested.	  Each	  lineage’s	  data	  is	  the	  read	  count	  found	  
with	  distinct	   cell	   types,	   as	  determined	  by	   cell	   surface	  markers,	   and	   the	  Bayesian	  network	  
asserts	  conditional	  independencies	  between	  read	  counts	  of	  certain	  cell	  types.	  One	  can	  then	  
determine	   the	   likelihood	   of	   the	   data	   given	   a	   network,	   and	   identify	   which	   network	   of	  
conditional	   dependencies	   better	   describes	   the	   data.	   In	   Biasco	   et.	   Al	   [12],	   Bayesian	  
Information	   Criterion	   (BIC)	   was	   employed	   to	   assess	   which	   network	   provided	   a	   better	  
description	   of	   the	   data.	   To	   encode	   a	   preference	   for	   a	   parsimonious	   description,	   the	   BIC	  
score	   is	   based	   on	   a	   combination	   of	   the	   likelihood	   of	   the	   data	   given	   the	   network	   and	   a	  
penalization	   term	   based	   on	   the	   number	   of	   free	   parameters	   of	   the	   model.	   To	   infer	   a	  
hematopoietic	   network	   within	   the	   constraints	   of	   the	   preferred	   Bayesian	   network,	   and	  
differentiation	  rates	  between	  cell	  types,	  a	  Markovian	  stochastic	  model	  is	  described	  in	  which	  
times	   to	   divide,	   die	   and	   differentiate	   between	   cell	   types	   are	   assumed	   to	   be	   independent	  
exponentially	   distributed	   random	   variables	   that	   are	   cell-­‐type	   dependent,	   but	   lineage-­‐
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independent.	  For	  reconstitution	  dynamics,	  this	  system	  begins	  out	  of	  steady	  state	  with	  singly	  
barcoded	  HSPCs	  that	  produce	  waves	  of	  barcoded	  downstream	  cell	  types.	  In	  order	  to	  fit	  the	  
parameters	   of	   the	   model,	   a	   diffusion	   approximation	   to	   this	   Markov	   process	   is	   first	  
employed,	   followed	   by	   a	   discretized	   Euler-­‐Maruyama	   approximation	   to	   the	   stochastic	  
differential	   equation.	   Under	   these	   assumptions,	   the	   transient	   reconstitution	   dynamics	  
reveal	  assumed	  steady	  state	  lineage	  independent	  dynamic	  fluxes.	  
Conclusions	  and	  Perspectives	  
	  
These	   recent	   single	   cell	   methods	   have	   revealed	   significant	   heterogeneity	   in	   apparently	  
homogenous	  cell	   intermediates,	  stimulated	  revisions	  to	  the	  topology	  of	   the	  tree	  and	  shed	  
light	  on	  the	  dynamics	  of	  naïve	  hematopoiesis.	  These	  novel	  findings	  are	  adding	  complexities	  
to	   the	   hematopoietic	   tree,	   and	   there	   is	   still	   much	   to	   be	   learned	   from	   the	   application	   of	  
these	  single	  cell	  methods,	  individually	  and	  in	  combination.	  Moreover,	  as	  one	  would	  expect	  
with	   recently	   developed	   methodologies,	   innovation	   continues	   apace	   on	   both	   the	  
experimental	  and	  theoretical	   fronts.	  Developments	   include,	   for	  example,	   in	  situ	  barcoding	  
schemes	   that	  are	  not	  based	  on	   transposon	   location,	  whose	  samples	  may	  prove	   to	  be	   less	  
costly	  and	  complex	  to	  process.	  	  
The	   diversity	   of	   the	   tasks	   (single	   cell	   sequencing,	   bioinformatics	   and	   inference	   analysis)	  
involved	  in	  these	  methods	  necessitates	  a	  multidisciplinary	  team,	  which	  gives	  rise	  to	  its	  own	  
challenges.	   As	   an	   illustration,	   certain	   versions	   of	   the	   hematopoietic	   tree	   are	   not	   directed	  
trees	  in	  the	  mathematical	  sense,	  which	  would	  require	  each	  cell	  type	  to	  have	  only	  one	  parent	  
[60].	   The	   biological	   sense	   of	   the	   tree	   is	   less	   restricted	   as	   some	   cell	   types	   have	   been	  
identified	   to	   have	  multiple	   parents	   and	   so	   form	   coalescent	   structures.	   As	   examples,	   both	  
CMPs	   and	   LMPPs	   are	   sometimes	   depicted	   as	   parents	   of	   GMPs	   [33],	   while	   it	   has	   been	  
proposed	   that	   DCs	   can	   come	   from	   several	   sources	   [19,26].	   This	   is	  more	   than	   a	   semantic	  
matter	   as	   most	   of	   inference	   methodologies	   that	   have	   been	   applied	   only	   search	   for	   tree	  
structures	   in	   the	   mathematical	   sense.	   As	   a	   possible	   direction,	   techniques	   that	   manage	  
different	  network	  structures	  could	  be	  developed,	  similar	  to	  those	  that	  have	  been	  developed	  
in	  evolutionary	  studies	  to	  manage	  horizontal	  gene	  transfer.	  
While	  we	  have	  focused	  on	  high	  dimensional	  data	  and	  barcoding-­‐based	  lineage	  tracing,	  there	  
are	   other	   single	   cell	   approaches	   that	   potentially	   hold	   promise	   for	   understanding	  
hematopoietic	  development.	  A	  cell’s	  DNA	  methylation	  state	   identifies	  epigenetic	  heritable	  
changes	   in	   gene	   expression	   within	   genotypically	   identical	   cells.	   Based	   on	   FACS	   sorted	  
classifications,	   this	   approach	   has	   been	   applied	   to	   population	   level	   hematopoietic	   data	  
[61,62],	   and	   one	   expects	   single	   cell	   results	   to	   appear	   soon.	   Micro-­‐Satellites	   (MSs),	   also	  
known	  as	  short	  tandem	  repeats,	  are	  short	  repeating	  motifs	  in	  DNA.	  With	  small	  likelihood,	  at	  
each	   cell	   division	   copying	   errors	   result	   in	   the	   removal	   of,	   or	   addition,	   of	   a	   motif.	   The	  
microsatellite	  state	  of	  different	  loci	  of	  single	  cells	  forms	  the	  basis	  of	  a	  natural	  lineage-­‐tracing	  
device	  from	  which	  one	  may	  be	  able	  to	  infer	  more	  than	  familial	  relatedness,	  but	  each	  cell’s	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entire	   in	   vivo	   family	   trees.	   While	   not	   yet	   applied	   to	   hematopoiesis,	   the	   experimental	  
approach	   has	   been	   considered	   for	   other	   systems	   [63–65]	   and	   a	   detailed	   comparison	   of	  
hierarchical	   clustering	   techniques	   to	   reconstruct	   the	   resulting	   family	   tree	   has	   been	  
published	   [66]	   Similarly	   to	  MS,	  methods	   using	   somatic	   base	   substitutions	   [67]	   are	   also	   of	  
potential	  interest	  as	  mutations	  present	  in	  the	  genome	  of	  a	  cell	  accumulate	  over	  the	  lifetime	  
of	  a	  multicellular	  organism.	  The	  lower	  frequency	  of	  mutation	  compared	  with	  MS	  may	  limit	  
their	   utility	   for	   studying	   hematopoiesis.	   Other	   artificial	   methods	   are	   under	   development	  
using	   genome	   editing	   to	   progressively	   introduce	   mutations	   in	   a	   DNA	   barcode	   that	  
accumulate	  over	  multiple	   rounds	  of	  cell	  division,	  but	  so	   far	   they	  have	  only	  be	  used	   in	  cell	  
lines	  and	  zebrafish	  [68].	  	  
As	   mentioned	   in	   the	   introduction,	   the	   hematopoietic	   tree	   serves	   as	   a	   summary	   whose	  
precise	  meaning	   is	   subject	   to	   interpretation.	   In	   light	  of	   these	  new	  single	   cell	  data	   sources	  
and	   the	   analysis	   of	   them,	   it	   is	   natural	   to	   question	   where	   it	   now	   stands.	   Substantial	  
heterogeneity	  in	  cells	  with	  the	  same	  FACS	  categorisation	  suggests	  that	  it	  is	  at	  best	  a	  course-­‐
grained	  description.	  Heterogeneity	   in	  offspring	  types	  produced	  downstream	  of	  a	  given	  cell	  
type,	   as	   revealed	   by	   barcoding,	   suggests	   that	   the	   tree	   should	   be	   regarded	   as	   a	  
amalgamation	  of	  all	  possible	  downstream	  progeny	  of	  single	  cells	  of	  a	  particular	  type,	  rather	  
than	  a	  description	  of	  what	  will	  be	  produced	  by	  each	  single	  cell.	  
These	   newfound	   complexities	   have	   driven	   scientists	   to	   attempt	   to	   find	   new	   ways	   of	  
summarizing	  hematopoietic	  development	  beyond	  the	  hematopoietic	  tree.	  To	  date,	  most	  of	  
these	   are	   similar	   in	   spirit	   to	   that	   found	   in	   Fig	   1B,	   which	   have	   a	   qualitative	   rather	   than	  
quantitative	   feel.	   To	   move	   things	   forward	   we	   suspect	   that	   the	   community	   really	   needs	  
something	  more	  precise,	  if	  only	  so	  that	  it	  can	  be	  explicitly	  tested	  and	  rejected.	  To	  that	  end,	  
our	   proposal	   is	   Fig	   2B.	   In	   it,	   we	   are	   explicitly	   saying	   that	   there	   is	   a	   finite	   collection	   of	  
developmental	  paths,	  which	  are	  programmed	  either	  intrinsically	  in	  the	  early	  stages	  of	  multi-­‐
potent	  capability	  or	  by	  the	  niche	  in	  which	  the	  multi-­‐potent	  cells	  finds	  themselves	  in.	  Under	  
that	  hypothesis,	   the	  hematopoietic	   tree	   is	   then	  an	  aggregate	  description,	   the	  union	  of	   all	  
those	  realized	  paths.	  	  
Going	   further	   to	   an	   even	   more	   quantitative	   description	   of	   in	   vivo	   hematopoietic	  
development,	   based	  on	  what	  has	  been	  discovered	   so	   far,	   there	   are	  missing	  pieces	  of	   the	  
puzzle	  that	  could	  be	  highly	  informative	  if	  filled	  in.	  For	  example,	  if	  one	  knew	  how	  many	  cell	  
divisions,	   on	   average,	   occur	   between	   related	   multi-­‐potent	   cells,	   this	   could	   aid	   in	  
determining	   an	   order	   of	   differentiation.	   By	   following	   histone-­‐GFP	   retention	   and	   dilution	  
over	  time	  [69–71]	  and	  the	  development	  of	  a	  inducible	  fluorescent	  tagging	  of	  HSCs	  followed	  
by	   observation	   of	   the	   fluorescent	   flux	   across	   FACs	   defined	   cell	   types	   over	   time	   [46],	  
population	   level	   inferences	   in	   this	   regard	   have	   been	  made.	   Alternate	   single	   cell	   systems	  
include	  the	  use	  of	  MS	  mutation	  state	  [72],	  as	  well	  as	  a	  proposal	  for	  the	  design	  of	  a	  genetic	  
delabeling	   construct	   [73],	   to	   infer	   tree	  depth.	   If	   tree	  depth	   could	  be	  measured	   in	  parallel	  
with	   any	   of	   the	   single	   cell	   techniques	   covered	   in	   this	   review,	   it	  will	   inform	   the	   inference	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approaches	  and	  should	  lead	  to	  additional	  hypothesis	  discrimination	  on	  the	  tree’s	  structure.	  	  
Answering	   the	   question	   of	   where	   the	   extensive	   heterogeneity	   arises	   and	   how	   it	   can	   be	  
influenced	  is	  a	  challenging	  one	  that	  is	  essential	  to	  further	  our	  understanding	  of	  the	  roles	  of	  
single	   cells	   in	   hematopoietic	   development.	   That	   diversity	   could	   result	   in	   programming	   by	  
niches,	   external	   environmental	   signalling,	   quorum	   sensing	   style	   co-­‐operative	   behaviour,	  
internal	   stochastic	  programming	  or	  a	  combination	  of	  all	  of	   them.	   Identifying	   their	   relative	  
importance	   could	   lead	   to	   an	   unprecedented	   quantitative	   description	   of	   hematopoietic	  
development.	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Box	  1:	  FACS	  defined	  cell	  types	  
	  
Mouse	  
Hematopoietic	  Stem	  Cell	   	   	   HSC	   	   lin-­‐Sca1+c-­‐kit+CD150+CD48-­‐	  
Multi-­‐potent	  Progenitor	   	   	   MPP	   	   lin-­‐Sca1+c-­‐kit+CD150-­‐Flt3+	  	  
Lymphoid-­‐primed	  Multi-­‐potent	  Progenitor	  	   LMPP	  	   	   lin-­‐Sca1+c-­‐kit+CD150-­‐Flt3high	  
Common	  Lymphoid	  Progenitor	  	   	   CLP	   	   lin-­‐Sca1lowc-­‐kitlowIL7Rα+	  
Common	  Myeloid	  Progenitor	  	  	   	   CMP	  	   	   lin-­‐Sca1-­‐c-­‐kit+CD34+CD16/32low	  
Granulocyte-­‐macrophage	  progenitors	  	   GMP	  	   	   lin-­‐Sca1-­‐c-­‐kit+CD34+CD16/32+	  
Megakaryocyte-­‐Erythrocyte	  Progenitor	   MEP	   	   lin-­‐Sca1-­‐c-­‐kit+CD34-­‐CD16/32-­‐	  
	  
Human	  
HSC	   CD34+CD38-­‐CD90+CD45RA-­‐CD49f+	  
MPP	   CD34+CD38-­‐CD90-­‐CD45RA-­‐CD49f-­‐	  
CLP	   CD34+	  CD45RA+CD10+CD7+	  
CMP	   CD34+CD38+CD123medCD135+CD45RA-­‐	  
	   24	  
GMP	   CD34+CD38+CD123medCD135+CD45RA+	  
MEP	   CD34+CD38+CD123-­‐CD135-­‐CD45RA-­‐CD110+	  
	  
Figure	  legends	  
Figure	  1:	  Possible	  hematopoietic	  trees.	  	  
A.	   Classical	   tree.	  M=all	   the	  myeloid	   cells	   including	  megakaryoctes	   and	   erythrocytes;	   L=all	  
lymphoid	   cells	   including	   natural	   killer	   cells;	   DC=dendritic	   cells.	   B.	   Alternative	   tree	   derived	  
from	  single	  cell	   results.	   In	  this	  network,	  HSCs	  and	  MPPs	  are	  a	  heterogeneous	  pool	  of	  cells	  
that	  have	  intrinsic	  biases	  towards	  certain	  differentiation	  decisions,	  even	  if	  decisions	  are	  not	  
irreversible.	   K=megakaryocytes;	   E=erythrocytes;	   M=granulocytes,	   monocytes,	   etc.;	   DC=	  
dendritic	  cells;	  B/T=B	  and	  T	  lymphocytes;	  NK=natural	  killer	  cells.	  
	  
Figure	  2:	  Two	  possible	  interpretations	  of	  the	  hematopoietic	  tree,	  using	  the	  classical	  tree	  as	  
an	  example.	  
A.	   Every	   cell	   gives	   rise	   to	   all	   cell	   types	   beneath	   it,	   or	   merely	   could	   do	   so	   with	   the	   right	  
stimuli.	   B.	   Trajectories	   of	   individual	   cells	   are	   summarized	   in	   one	   tree.	   Putative	   individual	  
trajectories	  here	  are	  given	  as	  examples	  whose	  union	  would	  cover	  the	  standard	  tree.	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Table	  1:	  Technical	  abilities	  and	  fundamental	  limitations	  of	  each	  method	  	  















Table	  1	  :	  Technical	  abilities	  and	  fundamental	  limitations	  of	  each	  method	  
	  	  
Cells	  can	  be	  used	  for	  
functional	  assay	  
afterwards	  
Invasiveness	   Categorization	  of	  the	  cells	  prior	  to	  analysis	  





Dynamics	  (time	  course,	  




measurement	  of	  cell	  
state	  
	  	   	  	   	  	   	  	   	  	   	  	   	  	  




Mass	  cytometry	  	   no	   no	   NA	   milllions	   NA	   single	  snap-­‐shots,division	  information	  (cyclins	  or	  IdU)	  
mouse,	  
human	  
Barcoding	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  








yes,	  achieved	  by	  facs	   thousands	  of	  initial	  cells	   good	  
single	  snap-­‐shots,	  no	  












yes,	  achieved	  by	  facs	   thousands	  of	  initial	  cells	   medium	  
sequential	  snap-­‐shots	  
within	  single	  hosts,	  no	  




Transposon	  in	  situ	  
barcoding	   no	  
no	  invasivity	  but	  
possible	  effects	  of	  
the	  inducible	  
system	  
no,	  all	  the	  cells	  with	  
the	  construct	  are	  
labelled	  
thousands	  of	  initial	  
cells	  
good	  but	  no	  
quantification	  
single	  snap-­‐shots,	  no	  
information	  on	  divisions	   mouse	  
Table	  2	  :	  Basic	  assumptions	  of	  each	  inference	  method	  	  






measurement	  of	  cell	  state	   	  	   	  	   	  	   	  	  
RNAseq	  
assumed	  to	  exist	  if	  
data	  is	  first	  clustered	  
before	  tree	  inference.	  
to	  be	  inferred	  either	  
from	  clustered	  data	  or	  
dimensionally	  reduced	  
non-­‐clustered	  data.	  	  
yes	  
phylogenetic	  inference	  on	  clustered	  data;	  
pseudo-­‐time	  machine	  learning	  
approaches	  on	  non-­‐clustered	  data.	  
Cytoff	  
assumed	  to	  exist	  if	  
data	  is	  first	  clustered	  
before	  tree	  inference.	  
to	  be	  inferred	  either	  
from	  clustered	  data.	  
Only	  paths,	  rather	  
than	  trees,	  inferred	  
for	  non-­‐clustered.	  	  
yes	  
hierarchical	  clustering	  and	  phylogenetic	  
inference	  on	  clustered	  data.	  Pseudo-­‐time	  
machine	  learning	  of	  single	  paths.	  
Barcoding	   	  	   	  	   	  	   	  	  
Cellular	  barcoding	   existing	  FACS	  




stochastic	  modelling	  for	  transient	  
populations	  assuming	  convergence	  to	  
final	  state.	  
Integration	  site	   existing	  FACS	   previously	  published	  tree/trees	   no	  
stochastic	  modelling	  assuming	  stationary	  
behaviour;	  Bayesian	  inference	  followed	  
by	  mean	  field	  stochastic	  	  modelling	  
assuming	  long	  run	  dynamics.	  
Transposon	  mouse	   existing	  FACS	   previously	  published	  tree	   no	   none	  yet.	  	  
